News
US Health and Human Services Secretary Alex Azar has said in an interview with Reuters, that it is within the Department of Health and Human...
Novo Nordisk's oral semaglutide reduced blood sugar (HbA1c) levels and assisted weight loss to a greater degree than placebo over 26 weeks of...
NHS Providers, the membership organisation and trade association for professionals working in the NHS, has warned that the NHS is unprepared for...
AstraZeneca's Tagrisso has been approved in Japan as a first-line therapy in patients with inoperable or recurrent epidermal growth factor...
A further six senior officials from the China Food and Drug Administration (CFDA) have been fired in relation to the Changsheng Biotechnology...
A study conducted by MIT’s Picower Institute for Learning and Memory has reinforced the notion that loss in the capacity for plasticity rather than...
The FDA have approved Bristol Myers Squibb’s Opdivo (nivolumab) for patients with metastatic small-cell lung cancer (SCLC), as the first and only...
Regeneron is celebrating the approval in the US of its vascular endothelial growth factor (VEGF) inhibitor Eylea (aflibercept) for the treatment of...
The Mississippi based manufacturer Westminster Pharmaceuticals is voluntarily recalling thyroid medications Levothyroxine and Liothyronine after...
The number of children and young people suffering from type-2 diabetes has increased in England in Wales over the past four years, according to...
Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches
